309 results
Page 2 of 16
6-K
EX-99
7hh8mhtdy36s42uuelou
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
7m7ief4 36lg54
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
kpcy77htsk7165jextf2
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
6-K
EX-99
h9dxa aav
28 Sep 23
BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 Combination
7:11am
6-K
EX-99
e54 ax5c2u
11 Sep 23
BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple
7:07am
6-K
EX-99
jykc6dr4c2ho439 ssj
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
9bjtj
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
f7wmur 0z4cipj7y
30 Aug 23
Current report (foreign)
6:45am
6-K
szgn9 vnjvmq7ujynkew
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
rn55jb eaja
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-1
fkn9ur3ndw830bh4x2
17 Jul 23
BioLineRx Announces Initiation of Randomized Phase 2 Clinical Trial in First Line Metastatic
7:10am
6-K
EX-99
jgi8k
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
51xp1jsnjoc2bmsrd
25 Apr 23
Current report (foreign)
7:07am
6-K
EX-99
8r2n6 j1c7a6hgfo87
17 Apr 23
BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating
11:08am
6-K
EX-99
ctbndya
20 Dec 22
BioLineRx Announces Results from Phase 1/2a Study of Investigational
7:08am
6-K
EX-99
7jmaju im8o3
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
d6xaut6lhp8sm8 mhv8
10 Nov 22
Current report (foreign)
7:08am
6-K
EX-99
b0n40r0k6w6 wc5hrbm
4 Nov 22
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
4:35pm
6-K
EX-99
ev3d guhia
3 Nov 22
BioLineRx Announces Presentations on Cost-Effectiveness of Motixafortide in Multiple Myeloma
9:20am
6-K
EX-99
9mz4ixc2xjmz
27 Sep 22
BioLineRx Announces U.S. Commercialization Plan for APHEXDA (Motixafortide) in Stem Cell Mobilization
7:00am